# SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance

> **NCT07503717** · NA · RECRUITING · sponsor: **Royal College of Surgeons, Ireland** · enrollment: 69 (estimated)

## Conditions studied

- Breast Cancer
- HER2-Positive Metastatic Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Brain Magnetic Resonance Imaging (MRI) with Contrast

## Key facts

- **NCT ID:** NCT07503717
- **Lead sponsor:** Royal College of Surgeons, Ireland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2028-06-01
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07503717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07503717, "SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07503717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*